Tiziana Life Sciences (TLSA) Shares Outstanding (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Shares Outstanding (Entity) for 9 consecutive years, with $118.3 million the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 10.88% year-over-year to $118.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $118.3 million (up 10.88% YoY) and the FY2025 annual result came in at $118.3 million, up 10.88% from the prior year.
• Shares Outstanding (Entity) climbed to $118.3 million in Q4 2025 per TLSA's latest filing, from $116.8 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for TLSA reached as high as $210.0 million in Q2 2021 and fell as low as $97.9 million in Q4 2021.
• A 5-year average of $115.7 million and a median of $102.8 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 53.36% — and 2025, when it rose 13.32%.
• Year by year, Shares Outstanding (Entity) stood at $97.9 million in 2021, then increased by 3.67% to $101.5 million in 2022, then rose by 0.93% to $102.5 million in 2023, then climbed by 4.1% to $106.7 million in 2024, then grew by 10.88% to $118.3 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $118.3 million, $116.8 million, and $106.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.